Literature DB >> 26491036

Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis.

Magdalena Sarah Volz1, Verena Moos2, Kristina Allers2, Enno Luge3, Anne Mayer-Scholl3, Karsten Nöckler3, Christoph Loddenkemper4, Andreas Jansen5, Thomas Schneider2.   

Abstract

Clinical manifestations of leptospirosis are highly variable: from asymptomatic to severe and potentially fatal. The outcome of the disease is usually determined in the immunological phase, beginning in the second week of symptoms. The underlying mechanisms, predictive factors, and individual immune responses that contribute to clinical variations are not well understood. The aim of this study was to determine the specifics of CD4(+) T-cell reactivity and cytokine release after stimulation with leptospiral antigens in patients with leptospirosis of different disease severities (patients with mild and severe symptoms) and in control subjects (with and without proven exposure to Leptospira). Whole-blood specimens were stimulated with Leptospira antigens in vitro. Subsequently, intracellular staining of cytokines was performed, and flow cytometry was used to assess the expression of CD40 ligand (CD40L) and the production of gamma interferon (IFN-γ), interleukin-10 (IL-10), IL-2, and tumor necrosis factor alpha (TNF-α) by CD4(+) T cells. The production of inflammatory cytokines such as TNF-α by CD4(+) T cells after stimulation with leptospiral antigens was highest in patients with severe disease. In contrast, the ratio of IL-10 production to TNF-α production was higher in exposed subjects than in patients with mild and severe disease. Levels of proinflammatory cytokines such as TNF-α may be useful markers of the severity of the immunological phase of leptospirosis. IL-10 production by T cells after antigen-specific stimulation may indicate a more successful downregulation of the inflammatory response and may contribute to an asymptomatic course of the disease.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491036      PMCID: PMC4658588          DOI: 10.1128/CVI.00397-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Comparison of two PCR systems for the rapid detection of Leptospira spp. from kidney tissue.

Authors:  Anne Mayer-Scholl; Angelika Draeger; Enno Luge; Rainer Ulrich; Karsten Nöckler
Journal:  Curr Microbiol       Date:  2010-12-04       Impact factor: 2.188

2.  Serum TNF-α, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome.

Authors:  Ioannis Kyriakidis; Pinelopi Samara; Anna Papa
Journal:  Cytokine       Date:  2011-02-12       Impact factor: 3.861

3.  Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis.

Authors:  H Tajiki; R Salomão
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

Review 4.  Protection and pathology during parasite infection: IL-10 strikes the balance.

Authors:  S A Redpath; N M Fonseca; G Perona-Wright
Journal:  Parasite Immunol       Date:  2014-06       Impact factor: 2.280

5.  Immune receptors and adhesion molecules in human pulmonary leptospirosis.

Authors:  Fabiola Del Carlo Bernardi; Bruno Ctenas; Luiz Fernando Ferraz da Silva; Antonio Carlos Nicodemo; Paulo Hilário Nascimento Saldiva; Marisa Dolhnikoff; Thais Mauad
Journal:  Hum Pathol       Date:  2012-03-19       Impact factor: 3.466

6.  Human leptospirosis--a review of 50 cases.

Authors:  H Lecour; M Miranda; C Magro; A Rocha; V Gonçalves
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

7.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

8.  Severe Pulmonary Involvement in Leptospirosis: Alternate antibiotics and systemic steroids.

Authors:  B Jayakrishnan; Fatma Ben Abid; Abdullah Balkhair; Juma K Alkaabi; Omar A Al-Rawas; Jojy George; Khalfan Al-Zeedy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

9.  Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells.

Authors:  Gary R Klimpel; Michael A Matthias; Joseph M Vinetz
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

10.  IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection.

Authors:  Ana Paula Freitas do Rosário; Tracey Lamb; Philip Spence; Robin Stephens; Agathe Lang; Axel Roers; Werner Muller; Anne O'Garra; Jean Langhorne
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

View more
  10 in total

1.  IL-10 Deficiency Protects Hamsters from Leptospira Infection.

Authors:  Xufeng Xie; Tianbao Lv; Dianjun Wu; Haozhe Shi; Shilei Zhang; Xunde Xian; George Liu; Wenlong Zhang; Yongguo Cao
Journal:  Infect Immun       Date:  2021-12-13       Impact factor: 3.609

Review 2.  Going Micro in Leptospirosis Kidney Disease.

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul; Marcus J Schultz; Arjen M Dondorp
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

Review 3.  Pathogenic Leptospira: Advances in understanding the molecular pathogenesis and virulence.

Authors:  Ciamak Ghazaei
Journal:  Open Vet J       Date:  2018-01-20

4.  Inbred Rats as a Model to Study Persistent Renal Leptospirosis and Associated Cellular Immune Responsiveness.

Authors:  Jarlath E Nally; Jennifer H Wilson-Welder; Richard L Hornsby; Mitchell V Palmer; David P Alt
Journal:  Front Cell Infect Microbiol       Date:  2018-03-14       Impact factor: 5.293

5.  Do the Th17 Cells Play a Role in the Pathogenesis of Leptospirosis?

Authors:  Kanchana Bandara; Chinthika Gunasekara; Manjula Weerasekera; Chamil Marasinghe; Nilantha Ranasinghe; Neluka Fernando
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-07-10       Impact factor: 2.471

Review 6.  Leptospirosis Pathophysiology: Into the Storm of Cytokines.

Authors:  Julie Cagliero; Sharon Y A M Villanueva; Mariko Matsui
Journal:  Front Cell Infect Microbiol       Date:  2018-06-20       Impact factor: 5.293

7.  GroEL protein of the Leptospira spp. interacts with host proteins and induces cytokines secretion on macrophages.

Authors:  Joana Dias Ho; Luiz Eduardo Massao Takara; Denize Monaris; Aline Patrícia Gonçalves; Antonio Francisco Souza-Filho; Gisele Oliveira de Souza; Marcos Bryan Heinemann; Paulo Lee Ho; Patrícia Antonia Estima Abreu
Journal:  BMC Microbiol       Date:  2021-03-31       Impact factor: 3.605

8.  Can cytokines response play a role in the treatment of fatal leptospirosis?

Authors:  Ahmad Alikhani; Kimia Mahmoodi; Leyla Delavaryan; Ebrahim Salehifar; Ali Reza Rafiei; Mahmoud Sadeghi Zavare
Journal:  Caspian J Intern Med       Date:  2022

9.  Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK.

Authors:  Wei Pan; Huizhen Yu; Shujie Huang; Pengli Zhu
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

10.  Cytokine response in human leptospirosis with different clinical outcomes: a systematic review.

Authors:  Indika Senavirathna; Devarajan Rathish; Suneth Agampodi
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.